A Comprehensive QSAR Study on Antileishmanial and Antitrypanosomal Cinnamate Ester Analogues
Overview
Authors
Affiliations
Parasitic infections like leishmaniasis and trypanosomiasis remain as a worldwide concern to public health. Improvement of the currently available drug discovery pipelines for those diseases is therefore mandatory. We have recently reported on the antileishmanial and antitrypanosomal activity of a set of cinnamate esters where we identified several compounds with interesting activity against and . For a better understanding of such compounds' anti-infective activity, analyses of the underlying structure-activity relationships, especially from a quantitative point of view, would be a prerequisite for rational further development of such compounds. Thus, quantitative structure-activity relationships (QSAR) modeling for the mentioned set of compounds and their antileishmanial and antitrypanosomal activity was performed using a genetic algorithm as main variable selection tool and multiple linear regression as statistical analysis. Changes in the composition of the training/test sets were evaluated (two randomly selected and one by Kennard-Stone algorithm). The effect of the size of the models (number of descriptors) was also investigated. The quality of all resulting models was assessed by a variety of validation parameters. The models were ranked by newly introduced scoring functions accounting for the fulfillment of each of the validation criteria evaluated. The test sets were effectively within the applicability domain of the best models, which demonstrated high robustness. Detailed analysis of the molecular descriptors involved in those models revealed strong dependence of activity on the number and type of polar atoms, which affect the hydrophobic/hydrophilic properties causing a prominent influence on the investigated biological activities.
Nandi R, Sharma A, Priya A, Kumar D Mol Divers. 2024; .
PMID: 39653961 DOI: 10.1007/s11030-024-11070-w.
A QSAR Study for Antileishmanial 2-Phenyl-2,3-dihydrobenzofurans .
Bernal F, Schmidt T Molecules. 2023; 28(8).
PMID: 37110632 PMC: 10144340. DOI: 10.3390/molecules28083399.
Cai Z, Zafferani M, Akande O, Hargrove A J Med Chem. 2022; 65(10):7262-7277.
PMID: 35522972 PMC: 9150105. DOI: 10.1021/acs.jmedchem.2c00254.
Abiri A, Rezaei M, Zeighami M, Vaezpour Y, Dehghan L, KhorramGhahfarokhi M Inform Med Unlocked. 2021; 27:100787.
PMID: 34805481 PMC: 8591993. DOI: 10.1016/j.imu.2021.100787.
Alkyl and Aryl Derivatives Based on -Coumaric Acid Modification and Inhibitory Action against and .
Lopes S, Yepes L, Perez-Castillo Y, Robledo S, de Sousa D Molecules. 2020; 25(14).
PMID: 32664596 PMC: 7397144. DOI: 10.3390/molecules25143178.